Vanda Pharmaceuticals (VNDA) Non-cash Items (2009 - 2018)

Vanda Pharmaceuticals has disclosed Non-cash Items across 10 years of filings, most recently posting $3.3 million for Q1 2018.

• Non-cash Items for Q1 2018 came in at $3.3 million, down 70.06% year-over-year; the trailing twelve-month figure through Mar 2018 was $3.3 million (down 70.06% YoY), and the FY2017 annual result was $3.5 million, down 89.09% from the prior year.
• Non-cash Items came in at $3.3 million for Q1 2018 at Vanda Pharmaceuticals, down from $24.4 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $3.3 billion in Q2 2017 to a low of $3.3 million in Q1 2018.
• The 5-year median for Non-cash Items is $11.8 million (2014), against an average of $207.6 million.
• Peak annual rise in Non-cash Items reached 27679.78% in 2017, while the deepest fall reached 90.7% in 2017.
• Vanda Pharmaceuticals' Non-cash Items stood at $28.5 million in 2014, then plunged by 73.71% to $7.5 million in 2015, then jumped by 332.82% to $32.5 million in 2016, then fell by 24.75% to $24.4 million in 2017, then sank by 86.39% to $3.3 million in 2018.
• The last three Non-cash Items figures came in at $3.3 million (Q1 2018), $24.4 million (Q4 2017), and $3.4 million (Q3 2017), per Business Quant data.